COMMUNIQUÉS West-GlobeNewswire

B-Temia and Wistron Join Forces to Launch Keeogo™ in Asia
07/06/2018
B-Temia and Wistron form B-Temia Asia to bring Keeogo™ to the Asian Market QUEBEC CITY, June 07, 2018 (GLOBE NEWSWIRE) -- B-Temia Inc., a Canadian biorobotics technology company and market leader in human mobility, [...]
B-Temia et Wistron s'associent pour lancer Keeogo™ en Asie
07/06/2018
B-Temia et Wistron forment B-Temia Asia pour lancer Keeogo™ sur le marché asiatique QUÉBEC, 07 juin 2018 (GLOBE NEWSWIRE) -- B-Temia Inc., une entreprise canadienne de technologie biorobotique et chef de file du marché [...]
HempAmericana Completes Construction of High-Potency Seed Augmentation Greenhouse
07/06/2018
NEW YORK, June 07, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is excited to announce the full completion of its new state-of-the-art greenhouse [...]
Summit Therapeutics plc : Result of AGM
07/06/2018
Summit Therapeutics plc ('Summit' or the "'Company') Result of Annual General Meeting Oxford, UK, and Cambridge, MA, US, 7 June 2018 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) announces that all resolutions [...]
Biogen Enters Exclusive Option Agreement to Acquire TMS’ Phase 2 Asset for Acute Stroke
07/06/2018
TMS-007 is designed to restore blood flow following acute stroke, with an extended treatment window versus current standard of care Biogen to pay $4 million upfront and $18 million upon exercise of the option, plus [...]
Pacific Biosciences Launches Microbial Multiplexing Kit, New SMRT Grant Program
07/06/2018
New Tools Unveiled at ASM Annual Meeting Enable Microbiologists to Do More, See More Than Ever Before MENLO PARK, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California Inc., (Nasdaq:PACB) today [...]
Chimerix Receives Orphan Drug Designation from the FDA for Brincidofovir for the Treatment of Smallpox
07/06/2018
DURHAM, N.C., June 07, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that the U.S. Food and Drug Administration [...]
IMV Inc. Appoints Julia P. Gregory to Board of Directors
07/06/2018
HALIFAX, Nova Scotia, June 07, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (“IMV” or the “Corporation”) (Nasdaq:IMV) (TSX:IMV), a clinical stage immunotherapy company, announced today the addition of Julia P. Gregory to the [...]
Zafgen, Inc. Appoints Industry Veteran and Healthcare Policy Expert Dr. Wendy Everett to its Board of Directors
07/06/2018
Zafgen, Inc. also announces the retirements of Dr. Bruce Booth and Ms. Frances Heller from its Board of Directors BOSTON, June 07, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. , (Nasdaq:ZFGN) , a clinical-stage [...]
MPX Bioceutical Corporation to Host Investor Conference Call on June 12, 2018
07/06/2018
TORONTO, June 07, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (CSE:MPX) (OTC:MPXEF) today announced that it will hold a conference call to update investors on the recently completed US$40 million convertible [...]
Trillium Therapeutics Appoints Yaping Shou, MD, PhD as Chief Medical Officer
07/06/2018
TORONTO, June 07, 2018 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ:TRIL) (TSX:TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, announced today the [...]
FibroGen Announces Completion of Enrollment in U.S. Phase 3 Clinical Program for Roxadustat in Anemia Associated with Chronic Kidney Disease
07/06/2018
SAN FRANCISCO, June 07, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ:FGEN), a biopharmaceutical company, today announced the completion of patient enrollment in the Phase 3 studies supporting the U.S. new drug [...]
Resverlogix Highlights Potential to Develop Apabetalone as a Therapeutic for HIV-1 Eradication Utilizing the “Shock and Kill” Approach
07/06/2018
Based on a growing body of data demonstrating apabetalone’s beneficial attributes as a latency-reversing agent for advancing HIV-1 eradication, Resverlogix is seeking a partner for future development CALGARY, Alberta [...]
Sandoz Canada launches (Pr)Sandoz Levetiracetam® 1000 mg tablets as an adjunctive treatment of epilepsy
07/06/2018
Sandoz Canada is the first company in Canada to offer levetiracetam in the higher concentration 1000 mg, enabling patients to reduce the number of tablets they need to take daily. Pr Sandoz Levetiracetam ® is indicated [...]
Sandoz Canada lance (Pr)Sandoz Levetiracetam® en comprimés de 1 000 mg pour le traitement adjuvant de l’épilepsie
07/06/2018
Sandoz Canada est la première entreprise au Canada à offrir le lévétiracétam dans une concentration de 1 000 mg, ce qui permet aux patients de réduire le nombre de comprimés à prendre quotidiennement. Pr Sandoz [...]
Fluidigm and Genomenon to Offer Evidence-Based Genomic Panel Design Service
07/06/2018
Joint offering enables acceleration of genomic panel design for translational and clinical disease research SOUTH SAN FRANCISCO, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation announced today that it has [...]
Emergent BioSolutions Announces $50 Million Expansion of Baltimore Fill/Finish Facility
07/06/2018
Multi-year investment will support growth of contract development and manufacturing capabilities GAITHERSBURG, Md., June 07, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the beginning [...]
Bavarian Nordic A/S - Articles of Association
07/06/2018
Updated Articles of Association for Bavarian Nordic A/S Attachment BavarianNordicArticlesofAssociation.pdf
Athersys Announces Expansion of Collaboration With Healios
07/06/2018
Healios receives rights to develop and commercialize additional indications and Athersys receives $20 million in license fees, plus potential milestones payments and royalties Discussions extended for China and other [...]

Pages